載入...
Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade
In preclinical in vivo models of cancer, the induction of immunogenic cell death (ICD) sensitizes to subsequent immunotherapy. Several clinical trials now confirm that pretreatment with ICD-inducing anthracyclines sensitizes to immune checkpoint blockade targeting PD-1 and PD-L1 interaction. These f...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791413/ https://ncbi.nlm.nih.gov/pubmed/31646079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1637188 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|